MORGAN STANLEY - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,514
-21.3%
10,334
+4.2%
0.00%
Q4 2022$4,464
-93.6%
9,920
-87.4%
0.00%
Q3 2022$70,000
-21.3%
78,627
+1.5%
0.00%
Q2 2022$89,000
-92.7%
77,463
-88.9%
0.00%
Q1 2022$1,224,000
+25.9%
699,354
+133.1%
0.00%
Q4 2021$972,000
+98.8%
300,034
+146.4%
0.00%
Q3 2021$489,000
+264.9%
121,750
+48.7%
0.00%
Q2 2021$134,000
+83.6%
81,881
+113.2%
0.00%
Q1 2021$73,00038,409
+426666.7%
0.00%
Q4 2020$0
-100.0%
9
-99.9%
0.00%
Q3 2020$12,000
-42.9%
6,009
-40.0%
0.00%
Q2 2020$21,00010,009
+76892.3%
0.00%
Q1 2020$013
-23.5%
0.00%
Q4 2019$017
+41.7%
0.00%
Q3 2019$012
+33.3%
0.00%
Q2 2019$09
-75.0%
0.00%
Q1 2019$036
-41.0%
0.00%
Q4 2018$0
-100.0%
61
-46.5%
0.00%
Q3 2018$1,000
-66.7%
114
-77.2%
0.00%
Q2 2017$3,0005000.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 900,733$1,883,0001.44%
Sio Capital Management, LLC 1,501,998$3,139,0000.92%
CVI Holdings, LLC 704,900$1,473,0000.55%
Perceptive Advisors 8,476,496$17,466,0000.28%
Artal Group S.A. 2,974,000$6,216,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 880,000$1,839,0000.17%
DAFNA Capital Management LLC 275,000$575,0000.17%
J. Goldman & Co LP 1,018,285$2,128,0000.13%
MYDA Advisors LLC 100,000$209,0000.13%
683 Capital Management, LLC 526,466$1,100,0000.09%
View complete list of LEAP THERAPEUTICS INC shareholders